Literature DB >> 23292894

Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis.

Mehmet Celikbilek1, Serkan Dogan, Omer Ozbakır, Gökmen Zararsız, Hamit Kücük, Sebnem Gürsoy, Alper Yurci, Kadri Güven, Mehmet Yücesoy.   

Abstract

BACKGROUND: Blood neutrophil-to-lymphocyte (N/L) ratio is an indicator of the overall inflammatory status of the body, and an alteration in N/L ratio may be found in ulcerative colitis (UC) patients. The aims of this study were to investigate the utility of N/L ratio as a simple and readily available predictor for clinical disease activity in UC.
METHODS: Twenty-six patients and 28 healthy controls were enrolled in the study. The neutrophil and lymphocyte counts were recorded, and the N/L ratio was calculated from these parameters. The extent of disease classified according to the Montreal classification, clinical disease activity was evaluated using a modified Truelove-Witts severity index, and endoscopic disease activities were classified according to Schroder et al.
RESULTS: The serum N/L ratios of active patients were significantly higher than those of inactive UC and controls (P < 0.001). The optimum N/L ratio cut-off point for active UC was 2.47. There was no significant difference between inflammation parameters, disease extension, and disease activity.
CONCLUSION: Our results demonstrate that N/L ratio is higher in patients with active UC compared with controls and UC patients in remission and a cut-off value of 2.47 can be used to identify patients with active ulcerative colitis.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23292894      PMCID: PMC6807407          DOI: 10.1002/jcla.21564

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  23 in total

1.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

2.  Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma.

Authors:  Karim J Halazun; Mark A Hardy; Abbas A Rana; David C Woodland; Elijah J Luyten; Suhari Mahadev; Piotr Witkowski; Abbey B Siegel; Robert S Brown; Jean C Emond
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

3.  Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis.

Authors:  A Bitton; M A Peppercorn; D A Antonioli; J L Niles; S Shah; A Bousvaros; B Ransil; G Wild; A Cohen; M D Edwardes; A C Stevens
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

4.  Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention.

Authors:  Brendan K Duffy; Hitinder S Gurm; Vivek Rajagopal; Ritesh Gupta; Stephen G Ellis; Deepak L Bhatt
Journal:  Am J Cardiol       Date:  2006-02-13       Impact factor: 2.778

5.  Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis.

Authors:  Basem Azab; Neil Jaglall; Jean Paul Atallah; Ari Lamet; Venkat Raja-Surya; Bachir Farah; Martin Lesser; Warren D Widmann
Journal:  Pancreatology       Date:  2011-09-28       Impact factor: 3.996

6.  Predictive power of the relative lymphocyte concentration in patients with advanced heart failure.

Authors:  S R Ommen; D O Hodge; R J Rodeheffer; C G McGregor; S P Thomson; R J Gibbons
Journal:  Circulation       Date:  1998 Jan 6-13       Impact factor: 29.690

7.  Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Gareth Morris-Stiff; Carla Campbell; Rocio Lopez; Tarek Abu-Rajab Tamimi; Lisa Yerian; Nizar N Zein; Ariel E Feldstein
Journal:  Liver Int       Date:  2011-09-08       Impact factor: 5.828

8.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy.

Authors:  S Lichtiger; D H Present; A Kornbluth; I Gelernt; J Bauer; G Galler; F Michelassi; S Hanauer
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

9.  Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer.

Authors:  Khaled M Sarraf; Elizabeth Belcher; Evgeny Raevsky; Andrew G Nicholson; Peter Goldstraw; Eric Lim
Journal:  J Thorac Cardiovasc Surg       Date:  2008-08-29       Impact factor: 5.209

Review 10.  Current and future diagnostic approaches: from serologies to imaging.

Authors:  David H Bruining; Edward V Loftus
Journal:  Curr Gastroenterol Rep       Date:  2007-12
View more
  69 in total

1.  A novel predictive marker for the recurrence of nasal polyposis following endoscopic sinus surgery.

Authors:  Osman Fatih Boztepe; Taylan Gün; Meltem Demir; Özer Erdem Gür; Deniz Ozel; Harun Doğru
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-08-19       Impact factor: 2.503

2.  Neutrophil-lymphocyte ratio in patients with familial Mediterranean fever.

Authors:  Mehmet Celikbilek; Serkan Dogan; Lutfi Akyol; Elif Borekci; Gokmen Zararsiz; Mustafa Kozan; Ilhan Gunaydin
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

3.  The relationship between inflammatory marker levels and pulmonary tuberculosis severity.

Authors:  Ozlem Abakay; Abdurrahman Abakay; Hadice Selimoglu Sen; Abdullah C Tanrikulu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

4.  Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity.

Authors:  Cynthia E Cherfane; Luke Gessel; Dominic Cirillo; Miriam B Zimmerman; Steven Polyak
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

5.  Diagnostic Value of Neutrophil-Lymphocyte Ratios and Mean Platelet Volumes in the Activation of Recurrent Aphthous Stomatitis.

Authors:  Sinan Uluyol; Saffet Kilicaslan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-01-12

6.  Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD.

Authors:  Jie Lin; Binbin Xue; Jia Li; Huaqing Xu; Xiaming Huang; Zhichao Yao; Xiang Li; Junhui Xia
Journal:  Neurol Sci       Date:  2017-08-04       Impact factor: 3.307

7.  The significance of neutrophil-to-lymphocyte ratio in idiopathic epiretinal membrane.

Authors:  Funda Dikkaya; Sevil Karaman Erdur; Mustafa Ozsutcu; Rukiye Aydin; Mehmet Selim Kocabora; Cengiz Aras
Journal:  Int Ophthalmol       Date:  2017-06-12       Impact factor: 2.031

8.  Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis.

Authors:  Belkıs Nihan Coşkun; Mustafa Ferhat Öksüz; Selime Ermurat; Ayşe Nur Tufan; Nurdan Oruçoğlu; Akif Doğan; Ediz Dalkılıç; Yavuz Pehlivan
Journal:  Eur J Rheumatol       Date:  2014-09-01

9.  Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis.

Authors:  Shilpa Grover; Michael Dougan; Kevin Tyan; Anita Giobbie-Hurder; Steven M Blum; Jeffrey Ishizuka; Taha Qazi; Rawad Elias; Kruti B Vora; Alex B Ruan; William Martin-Doyle; Michael Manos; Lauren Eastman; Meredith Davis; Maria Gargano; Rizwan Haq; Elizabeth I Buchbinder; Ryan J Sullivan; Patrick A Ott; F Stephen Hodi; Osama E Rahma
Journal:  Cancer       Date:  2020-06-22       Impact factor: 6.860

10.  Opposite impact of Methylene tetrahydrofolate reductase C677T and Methylene tetrahydrofolate reductase A1298C gene polymorphisms on systemic inflammation.

Authors:  Koroush Khalighi; Gang Cheng; Seyedabbas Mirabbasi; Bahar Khalighi; Yin Wu; Wuqiang Fan
Journal:  J Clin Lab Anal       Date:  2018-02-03       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.